Exploration of Patient Self-medication Practices During and After Cancer in France (CASEME)

August 5, 2026 updated by: University Hospital, Clermont-Ferrand

Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response

The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire

Study Overview

Status

Completed

Conditions

Detailed Description

Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.

Study Type

Observational

Enrollment (Actual)

681

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

France
- - Clermont-Ferrand, France
    - CHU clermont-ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

Patients contacted by cancer patient's association

Description

Inclusion Criteria:

Past or active cancer

Exclusion Criteria:

Speaking French
Not living in France

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Self-medication Time Frame: day 1	declaration of a practice of self-medication	day 1

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Class of products used in self-medication Time Frame: day 1	non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements	day 1
Indication for self-medication Time Frame: day 1	For treatment of side-effects, improvements in anti-cancer effects	day 1
Origin of self-medication products Time Frame: day 1	pharmacy, market, internet, other	day 1
Perception of adverse effects and drug-drug interaction related to self medication Time Frame: day 1	yes / no	day 1
QLQ-C30 questionnaire Time Frame: day 1	Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties	day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Clermont-Ferrand

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Maraud J, Bedhomme S, Pereira B, Trevis S, Jary M, Balayssac D. Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study. Cancers (Basel). 2023 Jun 15;15(12):3190. doi: 10.3390/cancers15123190.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2021

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria